Levine and colleagues demonstrate that the effects of caloric restriction on hepatic gene expression, circulating acylcarnitines and body temperature are largely mediated by an increase in the daytime peak of NADH concentration in the liver.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Levine, D.C. et al. Nat. Metab. https://doi.org/10.1038/s42255-021-00498-1 (2021).
Ramsey, K. M. et al. Science 324, 651–654 (2009).
Simcox, J. et al. Cell Metab. 26, 509–522 (2017).
Titov, D. V. et al. Science 352, 231–235 (2016).
Levine, D. C. et al. Mol. Cell 78, 835–849 (2020).
Asher, G. et al. Cell 134, 317–328 (2008).
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. & Sassone-Corsi, P. Science 324, 654–657 (2009).
Lin, S. J., Ford, E., Haigis, M., Liszt, G. & Guarente, L. Genes Dev. 18, 12–16 (2004).
Anderson, R. M. et al. Science 302, 2124–2126 (2003).
Sallin, O. et al. eLife 7, e32638 (2018).
Cambronne, X. A. et al. Science 352, 1474–1477 (2016).
Williamson, D. H., Lund, P. & Krebs, H. A. Biochem. J. 103, 514–527 (1967).
Zhang, Q., Piston, D. W. & Goodman, R. H. Science 295, 1895–1897 (2002).
Aguilar-Arnal, L. et al. Proc. Natl Acad. Sci. USA 113, 12715–12720 (2016).
Chen, D. et al. Genes Dev. 22, 1753–1757 (2008).
Acknowledgements
The authors received research support from the US National Institutes of Health (DK098656 to J.A.B.) and a Career Development Award from the Crohn’s & Colitis Foundation to K.C. (581355).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.A.B. is a consultant to Pfizer and Cytokinetics, an inventor on a patent for using NAD+ precursors in liver injury, and has received research funding and materials from Elysium Health and Metro International Biotech, both of which have an interest in NAD+ precursors. K.C. declares no competing interests.
Rights and permissions
About this article
Cite this article
Chellappa, K., Baur, J.A. Reducing NAD(H) to amplify rhythms. Nat Metab 3, 1589–1590 (2021). https://doi.org/10.1038/s42255-021-00494-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-021-00494-5